An increased risk of being rehospitalised for bleeding in people with non-valvular AF taking dabigatran compared to warfarin could be mitigated by monitoring drug plasma levels, researchers suggest. “Dabigatran works rapidly following its initiation; hence it may lead to more early-onset bleeds,” said Professor Chan, lead investigator on the study and Associate Professor in the department ...
Monitoring DOAC levels not the answer
By Sunalie Silva
5 Oct 2017